Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial

Jason V. Baker, Shweta Sharma, Birgit Grund, Adam Rupert, Julia A. Metcalf, Mauro Schechter, Paula Munderi, Inka Aho, Sean Emery, Abdel Babiker, Andrew Phillips, Jens D. Lundgren, James D. Neaton, H. Clifford Lane, INSIGHT START Strategic Timing

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
Article number262
JournalOpen Forum Infectious Diseases
Volume4
Issue number4
Number of pages9
ISSN2328-8957
DOIs
Publication statusPublished - 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • coagulation
  • comorbidities
  • end-organ disease
  • HIV disease
  • inflammation risk
  • HIV-INFECTED PATIENTS
  • C-REACTIVE PROTEIN
  • ANTIRETROVIRAL THERAPY
  • D-DIMER
  • CIRCULATING MARKERS
  • PLASMA-LEVELS
  • BIOMARKERS
  • COHORT
  • AIDS
  • ACTIVATION
  • 3121 Internal medicine

Cite this

Baker, J. V., Sharma, S., Grund, B., Rupert, A., Metcalf, J. A., Schechter, M., ... INSIGHT START Strategic Timing (2017). Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial. Open Forum Infectious Diseases, 4(4), [262]. https://doi.org/10.1093/ofid/ofx262
Baker, Jason V. ; Sharma, Shweta ; Grund, Birgit ; Rupert, Adam ; Metcalf, Julia A. ; Schechter, Mauro ; Munderi, Paula ; Aho, Inka ; Emery, Sean ; Babiker, Abdel ; Phillips, Andrew ; Lundgren, Jens D. ; Neaton, James D. ; Lane, H. Clifford ; INSIGHT START Strategic Timing. / Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial. In: Open Forum Infectious Diseases. 2017 ; Vol. 4, No. 4.
@article{0d338979eea540dfbdb2b0ca59dd8fc2,
title = "Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial",
keywords = "coagulation, comorbidities, end-organ disease, HIV disease, inflammation risk, HIV-INFECTED PATIENTS, C-REACTIVE PROTEIN, ANTIRETROVIRAL THERAPY, D-DIMER, CIRCULATING MARKERS, PLASMA-LEVELS, BIOMARKERS, COHORT, AIDS, ACTIVATION, 3121 Internal medicine",
author = "Baker, {Jason V.} and Shweta Sharma and Birgit Grund and Adam Rupert and Metcalf, {Julia A.} and Mauro Schechter and Paula Munderi and Inka Aho and Sean Emery and Abdel Babiker and Andrew Phillips and Lundgren, {Jens D.} and Neaton, {James D.} and Lane, {H. Clifford} and {INSIGHT START Strategic Timing}",
year = "2017",
doi = "10.1093/ofid/ofx262",
language = "English",
volume = "4",
journal = "Open Forum Infectious Diseases",
issn = "2328-8957",
publisher = "Oxford University Press",
number = "4",

}

Baker, JV, Sharma, S, Grund, B, Rupert, A, Metcalf, JA, Schechter, M, Munderi, P, Aho, I, Emery, S, Babiker, A, Phillips, A, Lundgren, JD, Neaton, JD, Lane, HC & INSIGHT START Strategic Timing 2017, 'Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial' Open Forum Infectious Diseases, vol. 4, no. 4, 262. https://doi.org/10.1093/ofid/ofx262

Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial. / Baker, Jason V.; Sharma, Shweta; Grund, Birgit; Rupert, Adam; Metcalf, Julia A.; Schechter, Mauro; Munderi, Paula; Aho, Inka; Emery, Sean; Babiker, Abdel; Phillips, Andrew; Lundgren, Jens D.; Neaton, James D.; Lane, H. Clifford; INSIGHT START Strategic Timing.

In: Open Forum Infectious Diseases, Vol. 4, No. 4, 262, 2017.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial

AU - Baker, Jason V.

AU - Sharma, Shweta

AU - Grund, Birgit

AU - Rupert, Adam

AU - Metcalf, Julia A.

AU - Schechter, Mauro

AU - Munderi, Paula

AU - Aho, Inka

AU - Emery, Sean

AU - Babiker, Abdel

AU - Phillips, Andrew

AU - Lundgren, Jens D.

AU - Neaton, James D.

AU - Lane, H. Clifford

AU - INSIGHT START Strategic Timing

PY - 2017

Y1 - 2017

KW - coagulation

KW - comorbidities

KW - end-organ disease

KW - HIV disease

KW - inflammation risk

KW - HIV-INFECTED PATIENTS

KW - C-REACTIVE PROTEIN

KW - ANTIRETROVIRAL THERAPY

KW - D-DIMER

KW - CIRCULATING MARKERS

KW - PLASMA-LEVELS

KW - BIOMARKERS

KW - COHORT

KW - AIDS

KW - ACTIVATION

KW - 3121 Internal medicine

U2 - 10.1093/ofid/ofx262

DO - 10.1093/ofid/ofx262

M3 - Article

VL - 4

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

SN - 2328-8957

IS - 4

M1 - 262

ER -